chr17-8230304-T-C
Variant summary
Our verdict is Uncertain significance. Variant got 3 ACMG points: 3P and 0B. PM2PP5
The NM_025099.6(CTC1):āc.2923A>Gā(p.Arg975Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000317 in 1,611,172 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_025099.6 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 3 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000657 AC: 10AN: 152146Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000687 AC: 17AN: 247296Hom.: 0 AF XY: 0.0000671 AC XY: 9AN XY: 134208
GnomAD4 exome AF: 0.0000281 AC: 41AN: 1459026Hom.: 0 Cov.: 32 AF XY: 0.0000262 AC XY: 19AN XY: 725810
GnomAD4 genome AF: 0.0000657 AC: 10AN: 152146Hom.: 0 Cov.: 32 AF XY: 0.0000673 AC XY: 5AN XY: 74322
ClinVar
Submissions by phenotype
not provided Pathogenic:3
Published functional studies demonstrate a damaging effect with global genome instabilities under replication stress (Wang et al., 2018); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 23869908, 32033110, 24115768, 22267198, 32499435, 22387016, 34308104, 37495394, 37021555, 29481669) -
- -
- -
Dyskeratosis congenita Pathogenic:2Uncertain:1
This sequence change replaces arginine, which is basic and polar, with glycine, which is neutral and non-polar, at codon 975 of the CTC1 protein (p.Arg975Gly). This variant is present in population databases (rs199473678, gnomAD 0.02%). This missense change has been observed in individuals with Coats plus syndrome (PMID: 22267198, 22387016, 22899577). ClinVar contains an entry for this variant (Variation ID: 631531). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Possibly Damaging"; Align-GVGD: "Class C0"). Experimental studies have shown that this missense change affects CTC1 function (PMID: 23869908, 24115768, 29481669). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
- -
- -
Cerebroretinal microangiopathy with calcifications and cysts 1 Pathogenic:2
The CTC1 c.2923A>G (p.Arg975Gly) missense variant has been reported in two studies in which it is found in a compound heterozygous state with a null variant in two individuals with cerebroretinal microangiopathy with calcifications and cysts (CRMCC or Coats Plus syndrome) (Anderson et al. 2012; Polvi et al. 2012). The p.Arg975Gly variant was absent from 2,097 control subjects but is reported at a frequency of 0.000154 in the European (non-Finnish) population of the Genome Aggregation Database. Functional studies demonstrate that the p.Arg975Gly variant was found to reduce telomere association in vivo to 83% that of wild type, while other telomeric functions were found to be preserved, similar to those of wild type (Chen et al. 2013). Wang et al. (2018) showed that unlike wild type CTC1, the p.Arg975Gly variant failed to completely restore the chromosome abnormalities, RAD51 foci formation, and proliferation defects caused by CTC1 knockdown in cells and that the p.Arg975Gly variant significantly reduced CTC1 association to genomic fragile sites in response to replication stress indicating that this residue might be critical for RAD51 binding. Based on the evidence, the p.Arg975Gly variant is classified as likely pathogenic for CTC1-related disorders. This variant was observed by ICSL as part of a predisposition screen in an ostensibly healthy population. -
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at